Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical application

Introduction Hyperthermia (HT) at temperatures between 39 °C and 44 °C is utilized as an adjunctive cancer therapy, serving as potent radio- and chemosensitizer. Its effectiveness in treating solid malignancies has been well established. This raises the question of whether HT can also benefit patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Moritz V. Scharr, Frederik Damm, Paul Krahl, Anna Dieper, Paraskevi D. Veltsista, Alexander Hansch, Marcus Beck, Dominik Gerster, Anna-Chiara Giovannelli, Lars Bullinger, Daniel Zips, Pirus Ghadjar
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2418427
Tags: Add Tag
No Tags, Be the first to tag this record!